Altana AG
ALTANA AG: ALTANA AG sells pharmaceuticals business to Nycomed
Ad hoc announcement transmitted by DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
——————————————————————————
Ad – hoc
ALTANA AG sells pharmaceuticals business to Nycomed
Bad Homburg, September 21, 2006 – ALTANA AG (NYSE: AAA; FSE: ALT) announced
today the sale of ALTANA Pharma AG and its entire pharmaceuticals business
to Nycomed. The Supervisory Board of ALTANA AG has approved this
transaction today. The completion of the transaction is subject to approval
by the competent antitrust authorities in the EU and the U.S. It is also
subject to approval by an Extraordinary General Meeting of ALTANA AG which
will take place in December 2006. Closing is expected by the end of this
year. The transfer of the business is planned as of January 1, 2007.
The total purchase price to ALTANA AG is expected to amount to approx. €4.5
billion. This amount consists of a debt-free/cash-free valuation of ALTANA
Pharma AG of €4.215 billion and an additional amount of approx. €0.3
billion after price adjustment at closing (net cash/working capital). The
net proceeds of the transaction will be transferred to ALTANA AG’s
shareholders in 2007. The distribution will come in addition to the
dividend for the financial year 2006. It is planned that the Ordinary
Annual General Meeting (AGM) scheduled for May 3, 2007, will take the
decision on the distribution of the net proceeds and the dividend after
approval of the 2006 Financial Statements.
With the divestiture of its pharmaceutical activities, the previously
announced separation of ALTANA AG into two separate pharmaceuticals and
chemicals businesses will be completed. After the divestiture, ALTANA AG
will focus on its specialty chemicals business ALTANA Chemie. ALTANA AG
will maintain its stock exchange listing, and Susanne Klatten remains
majority shareholder.
(c)DGAP 21.09.2006
—————————————————————————
Language: English
Issuer: Altana AG
Am Pilgerrain 15
61352 Bad Homburg Deutschland
Phone: +49 (0)6172-1712-153
Fax: +49 (0)6172 1712-158
E-mail: thomas.gauly@altana.de
WWW: www.altana.de
ISIN: DE0007600801
WKN: 760080
Indices: DAX
Listed: Amtlicher Markt in Berlin-Bremen, Frankfurt (Prime Standard),
Düsseldorf; Freiverkehr in Hannover, Hamburg, München,
Stuttgart
End of News DGAP News-Service
—————————————————————————
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden